The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116189842 11618984 2 F 20121025 20160823 20151012 20160911 EXP PHHY2013JP040397 NOVARTIS 76.27 YR M Y 56.00000 KG 20160911 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116189842 11618984 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 1000 MG Y 22334 10 MG TABLET QD
116189842 11618984 2 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 1000 MG Y 22334 5 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116189842 11618984 1 Pancreatic neuroendocrine tumour
116189842 11618984 2 Neuroendocrine tumour

Outcome of event

Event ID CASEID OUTC COD
116189842 11618984 OT
116189842 11618984 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116189842 11618984 Anaemia
116189842 11618984 Atrial fibrillation
116189842 11618984 Blood albumin decreased
116189842 11618984 Cardiac failure
116189842 11618984 Cough
116189842 11618984 Decreased appetite
116189842 11618984 Dyspnoea
116189842 11618984 Hypoproteinaemia
116189842 11618984 Jaundice
116189842 11618984 Malignant neoplasm progression
116189842 11618984 Mitral valve incompetence
116189842 11618984 Oedema peripheral
116189842 11618984 Pleural effusion
116189842 11618984 Pneumonia bacterial
116189842 11618984 Pulmonary hypertension
116189842 11618984 Pyrexia
116189842 11618984 Stomatitis
116189842 11618984 Tricuspid valve incompetence
116189842 11618984 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116189842 11618984 1 20121004 20130111 0
116189842 11618984 2 20130321 20130513 0